The Journal of Pediatrics
Volume 152, Issue 1 , Pages 25-32, January 2008

Time Trends in Birth Incidence of Cystic Fibrosis in Two European Areas: Data from Newborn Screening Programs

  • Virginie Scotet, PhD

      Affiliations

    • Inserm U613, Brest, France
    • Univ of Brest, France
    • Blood center, Brest, France
    • Corresponding Author InformationReprint requests: Virginie Scotet, PhD, Inserm U613, Génétique Moléculaire et Génétique Épidémiologique, 46 Rue Félix Le Dantec, BP 62025, 29220 Brest Cedex 2, France.
  • ,
  • Baroukh M. Assael, MD

      Affiliations

    • Azienda Hospital, Cystic Fibrosis Center, Verona, Italy
  • ,
  • Ingrid Duguépéroux, PhD

      Affiliations

    • Inserm U613, Brest, France
    • Univ of Brest, France
    • Blood center, Brest, France
  • ,
  • Anna Tamanini, PhD

      Affiliations

    • Azienda Hospital, Laboratory of Chimical and Clinical Analyses and Hematologica, Verona, Italy.
  • ,
  • Marie-Pierre Audrézet, PhD

      Affiliations

    • Inserm U613, Brest, France
    • Univ of Brest, France
    • Blood center, Brest, France
    • Hospital of Brest, Laboratory of molecular genetics, Brest, France
  • ,
  • Claude Férec, MD, PhD

      Affiliations

    • Inserm U613, Brest, France
    • Univ of Brest, France
    • Blood center, Brest, France
    • Hospital of Brest, Laboratory of molecular genetics, Brest, France
  • ,
  • Carlo Castellani, MD

      Affiliations

    • Azienda Hospital, Cystic Fibrosis Center, Verona, Italy

Received 24 April 2007; received in revised form 5 July 2007; accepted 25 July 2007. published online 22 October 2007.

Objective

To determine the incidence of cystic fibrosis (CF) and its time trends over a 16-year period (1990 to 2005) in 2 European regions with a long history of newborn screening (NBS) for CF, and to investigate the impact of some external factors.

Study design

This study focused on data from NBS and prenatal diagnosis (PD) in Brittany (western France) and Veneto/Trentino Alto-Adige (northeastern Italy).

Results

Similar birth incidences of CF were observed in the 2 regions (1/3153 vs 1/3540; P = .245). Time trend analysis using Poisson regression revealed that the birth incidence decreased significantly in the Italian area only (average annual percent change [AAPC] = −4.7%; 95% confidence interval [CI] = −7.3 to −2; P = .0008). The use of PD appeared more common in Brittany, and considering the terminations of CF-affected fetuses, the adjusted incidence was 1/2191 in Brittany and 1/3116 in Veneto/Trentino, corresponding to variations of 30.5% (highly significant; P = .0002) and 12% (not significant; P = .16), respectively. Recording the reason for each PD allowed ready assessment of the affect of various public health policies on incidence. The affect of population mixing also appeared to be relevant in the Italian area.

Conclusions

This study highlights how the incidence of CF has evolved in 2 European regions that have different attitudes toward PD and immigration policy.

Abbreviations: AAPC, Average annual percent change, CF, Cystic fibrosis, CFTR, Cystic fibrosis transmembrane regulator conductance, CI, Confidence interval, IRT, Immunoreactive trypsinogen, NBS, Newborn screening, PD, Prenatal diagnosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a grant from the French CF Association “Vaincre La Mucoviscidose” and from the hospital program of clinical research “Evolution of the molecular epidemiology of CF in the western part of France.”

PII: S0022-3476(07)00709-3

doi:10.1016/j.jpeds.2007.07.046

Refers to article:

  • How Far Can Prenatal Screening Go in Preventing Birth Defects?

    David A. Savitz
    The Journal of Pediatrics January 2008 (Vol. 152, Issue 1, Pages 3-4)

  • Prevalence, Neonatal Characteristics, and First-Year Mortality of Down Syndrome: A National Study , 19 November 2007

    Michel E. Weijerman, A. Marceline van Furth, Antonie Vonk Noordegraaf, Jacobus P. van Wouwe, Chantal J.M. Broers, Reinoud J.B.J. Gemke
    The Journal of Pediatrics January 2008 (Vol. 152, Issue 1, Pages 15-19)

  • Is Down Syndrome a Disappearing Birth Defect? , 22 October 2007

    Veronica R. Collins, Evelyne E. Muggli, Merilyn Riley, Sonia Palma, Jane L. Halliday
    The Journal of Pediatrics January 2008 (Vol. 152, Issue 1, Pages 20-24.e1)

The Journal of Pediatrics
Volume 152, Issue 1 , Pages 25-32, January 2008